Stay updated on PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Sign up to get notified when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.

Latest updates to the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding a clinical trial for metastatic castration-resistant prostate cancer (mCRPC) and the addition of a new project reference. The revision number has also been updated.SummaryDifference40%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.